- Report
- October 2023
- 22 Pages
Latvia
From €825EUR$914USD£734GBP
- Report
- October 2023
- 22 Pages
Lithuania
From €825EUR$914USD£734GBP
- Report
- October 2023
- 22 Pages
North Macedonia
From €825EUR$914USD£734GBP
- Report
- October 2023
- 24 Pages
Slovakia
From €825EUR$914USD£734GBP
- Report
- October 2023
- 23 Pages
Sweden
From €825EUR$914USD£734GBP
- Report
- September 2023
- 22 Pages
Guatemala
From €825EUR$914USD£734GBP
- Report
- September 2023
- 22 Pages
Georgia
From €825EUR$914USD£734GBP
- Report
- September 2023
- 23 Pages
Kazakhstan
From €825EUR$914USD£734GBP
- Report
- September 2023
- 22 Pages
Indonesia
From €825EUR$914USD£734GBP
- Report
- September 2023
- 23 Pages
Egypt
From €825EUR$914USD£734GBP
- Report
- September 2023
- 26 Pages
Czech Republic
From €825EUR$914USD£734GBP
- Report
- September 2023
- 22 Pages
Estonia
From €825EUR$914USD£734GBP
- Report
- September 2023
- 21 Pages
Finland
From €825EUR$914USD£734GBP
- Report
- September 2023
- 27 Pages
Poland
From €825EUR$914USD£734GBP
- Report
- September 2023
- 25 Pages
Portugal
From €825EUR$914USD£734GBP
- Report
- September 2023
- 21 Pages
Romania
From €825EUR$914USD£734GBP
- Report
- September 2023
- 24 Pages
Saudi Arabia
From €825EUR$914USD£734GBP
- Report
- September 2023
- 23 Pages
Spain
From €825EUR$914USD£734GBP
- Report
- September 2023
- 20 Pages
Croatia
From €825EUR$914USD£734GBP
- Report
- September 2023
- 23 Pages
Netherlands
From €825EUR$914USD£734GBP
The Cold Sore Drug market is a subset of the Infectious Diseases Drugs market. Cold Sores, also known as fever blisters, are caused by the herpes simplex virus and are highly contagious. Cold Sore Drugs are used to treat the symptoms of the virus, such as pain, itching, and burning. These drugs can also help reduce the duration of the outbreak and prevent future outbreaks. Commonly used Cold Sore Drugs include antiviral medications, topical creams, and ointments.
The Cold Sore Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Johnson & Johnson. Other companies in the market include Sanofi, Bayer, and Mylan. Show Less Read more